chr17-37512426-G-C
Position:
Variant summary
Our verdict is Uncertain significance. Variant got 3 ACMG points: 3P and 0B. PM2PP3
The NM_007026.4(DUSP14):c.154G>C(p.Gly52Arg) variant causes a missense change involving the alteration of a conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Genomes: not found (cov: 31)
Consequence
DUSP14
NM_007026.4 missense
NM_007026.4 missense
Scores
4
4
7
Clinical Significance
Conservation
PhyloP100: 8.16
Genes affected
DUSP14 (HGNC:17007): (dual specificity phosphatase 14) Dual-specificity phosphatases (DUSPs) constitute a large heterogeneous subgroup of the type I cysteine-based protein-tyrosine phosphatase superfamily. DUSPs are characterized by their ability to dephosphorylate both tyrosine and serine/threonine residues. They have been implicated as major modulators of critical signaling pathways. DUSP14 contains the consensus DUSP C-terminal catalytic domain but lacks the N-terminal CH2 domain found in the MKP (mitogen-activated protein kinase phosphatase) class of DUSPs (see MIM 600714) (summary by Patterson et al., 2009 [PubMed 19228121]).[supplied by OMIM, Dec 2009]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Uncertain_significance. Variant got 3 ACMG points.
PM2
Very rare variant in population databases, with high coverage;
PP3
MetaRNN computational evidence supports a deleterious effect, 0.829
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
DUSP14 | NM_007026.4 | c.154G>C | p.Gly52Arg | missense_variant | 3/3 | ENST00000617516.5 | NP_008957.1 | |
DUSP14 | XM_005256977.4 | c.154G>C | p.Gly52Arg | missense_variant | 3/3 | XP_005257034.1 | ||
DUSP14 | XM_011524234.2 | c.154G>C | p.Gly52Arg | missense_variant | 3/3 | XP_011522536.1 | ||
DUSP14 | XM_047435217.1 | c.154G>C | p.Gly52Arg | missense_variant | 3/3 | XP_047291173.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
DUSP14 | ENST00000617516.5 | c.154G>C | p.Gly52Arg | missense_variant | 3/3 | 1 | NM_007026.4 | ENSP00000478595.1 | ||
DUSP14 | ENST00000613659.1 | c.154G>C | p.Gly52Arg | missense_variant | 3/3 | 2 | ENSP00000484091.1 | |||
DUSP14 | ENST00000614411.1 | c.154G>C | p.Gly52Arg | missense_variant | 2/2 | 2 | ENSP00000477653.1 |
Frequencies
GnomAD3 genomes Cov.: 31
GnomAD3 genomes
Cov.:
31
GnomAD4 exome Cov.: 31
GnomAD4 exome
Cov.:
31
GnomAD4 genome Cov.: 31
GnomAD4 genome
Cov.:
31
ClinVar
Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Aug 16, 2021 | The c.154G>C (p.G52R) alteration is located in exon 3 (coding exon 1) of the DUSP14 gene. This alteration results from a G to C substitution at nucleotide position 154, causing the glycine (G) at amino acid position 52 to be replaced by an arginine (R). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
AlphaMissense
Uncertain
BayesDel_addAF
Pathogenic
D
BayesDel_noAF
Uncertain
CADD
Benign
DANN
Benign
DEOGEN2
Benign
T;T;T
Eigen
Uncertain
Eigen_PC
Uncertain
FATHMM_MKL
Pathogenic
D
M_CAP
Benign
T
MetaRNN
Pathogenic
D;D;D
MetaSVM
Benign
T
MutationAssessor
Benign
L;L;L
PrimateAI
Pathogenic
D
Sift4G
Benign
T;T;T
Polyphen
D;D;D
Vest4
MutPred
Gain of MoRF binding (P = 0.0175);Gain of MoRF binding (P = 0.0175);Gain of MoRF binding (P = 0.0175);
MVP
ClinPred
T
GERP RS
Varity_R
gMVP
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
No publications associated with this variant yet.